Clinical Evaluation Of Ayurvedic Arka Nebulization In Tamak Shwasa

Comparative Clinical Evaluation Of Vasa Kantakari And Pushkarmoola Arka Nebulization In Tamak Shwasa - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094665

Enrollment

Registered

2025-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age between 5 year to 15 years. Sex both male and female. Diagnosed cases of bronchial asthma. Mild to moderate case of bronchial asthma. Case of productive and unproductive cough. Case of acute or chronic cough. Occasionally vomiting present

Exclusion criteria

Exclusion criteria: Severe case of bronchial asthma. Severe pneumonia Status asthamaticus Any associated bleeding disorder or sign of any severe illness. Child suffering from life threatening conditions. Cardiac asthma Case of pleural effusion, pneumothorax and pulmonary tuberculosis etc. Cough which is associated with blood Children less then 5 years and more than 15 years

Design outcomes

Primary

Measure	Time frame
changes in clinical symptoms of asthma like breathlessness cough wheezing etc per week frequency of asthmatic attacks before and after treatment PEFR AEC other laboratory investigation will be observed before and after treatment.Timepoint: 1st follow up day 1, 2nd follow up day 7, 3rd follow up day 15	—

Secondary

Measure	Time frame
To evaluate whether the drug works as bronchodilator or notTimepoint:	—

Countries

India

Contacts

Public ContactDr Rahul Sharma

Patanjali Bhartiya Ayurvigyan Evan Anusandhan Sansthan Haridwar

pwadhwa13@gmail.com8105938269

Outcome results